An mRNA vaccine suppressed abnormal blood vessel growth or neovascularization in the retina of AMD mouse models.
A new mRNA vaccine developed in Japan has been shown to suppress abnormal blood vessel growth in the retina of mice, offering hope to millions of patients with age-related vision loss.
Previous studies have already established AP’s ability to arrest liver-stage development in the rodent malaria model, P.